The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019.
- DOI
- 10.1016/j.biologicals.2020.02.005
- Published
- 2020 May
- Container
- Biologicals : journal of the International Association of Biological Standardization
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.biologicals.2020.02.005,
title = {The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019.},
author = {Kang HN and Thorpe R and Knezevic I and Survey participants from 19 countries},
year = {2020},
journal = {Biologicals : journal of the International Association of Biological Standardization},
doi = {10.1016/j.biologicals.2020.02.005},
url = {https://doi.org/10.1016/j.biologicals.2020.02.005}
}RIS
TY - JOUR TI - The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019. AU - Kang HN AU - Thorpe R AU - Knezevic I AU - Survey participants from 19 countries PY - 2020 JO - Biologicals : journal of the International Association of Biological Standardization DO - 10.1016/j.biologicals.2020.02.005 UR - https://doi.org/10.1016/j.biologicals.2020.02.005 ER -
APA
HN, K., R, T., I, K., & countries, S. P. F. 1. (2020). The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019.. Biologicals : journal of the International Association of Biological Standardization. https://doi.org/10.1016/j.biologicals.2020.02.005
Source records
- pubmed · retrieved 2026-09-25T19:34:48.200Z